Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Neu-Isenburg

12 clinical trials in Neu-Isenburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Neu-Isenburg at a glance
12
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Neu-Isenburg

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Cough

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Camlipixant
  • Sponsor:Bellus Health Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Astegolimab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.

Asthma

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:GSK5784283
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Neu-Isenburg

What the registry says about research in the country

01 Asthma Research

Clinical studies focusing on severe asthma and its treatment, particularly investigating new antibody therapies and their effectiveness in managing respiratory symptoms.

  • Anti-TSLP antibody evaluation
  • Eosinophilic phenotype treatments
  • Rescue medication assessment

These trials aim to advance treatment options for patients with uncontrolled and severe asthma conditions.

02 Chronic Cough Studies

Innovative research investigating treatments for refractory chronic cough, including unexplained cases, through controlled clinical trials.

  • 24-week efficacy studies
  • Novel therapeutic compounds
  • Cough frequency monitoring

Research focused on developing solutions for patients with persistent cough conditions resistant to standard treatments.

03 Allergic Conditions

Research examining immunotherapy treatments for allergic rhinitis and rhinoconjunctivitis related to house dust mite sensitivity.

  • Subcutaneous immunotherapy
  • Combined symptom assessment
  • Long-term treatment evaluation

Studies aimed at improving quality of life for patients with moderate to severe allergic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.